China Resources Boya Bio-pharmaceutical Group (300294): Deeply engaged in the Blood Product field, acquiring Green Cross to expand its Industry landscape.

The demand side of the Blood Product Industry is still continuing to expand, while the resource supply side is limited, creating a favorable competitive landscape in the industry. Currently, the two largest varieties of Blood Products are albumin and intravenous immunoglobulin, among which the domestic terminal sales of albumin have exceeded 32 billion yuan, while intravenous immunoglobulin is affected by the epidemic.

Northeast SecuritiesDec 30, 2024 00:00

CHINARES PHARMA (03320) subsidiary CHINARES PHARMA Holdings' Shareholding in China Resources Boya Bio-pharmaceutical Group has reached 1%.

CHINARES PHARMA (03320) announced that between November 8, 2024, and December 18, 2024, public...

Zhitong FinanceDec 18, 2024 22:36

Express News | China Resources Boya Bio-pharmaceutical Group: After the controlling Shareholder increased its shareholding by 1%, plans to continue increasing by no more than 0.2% of the total share capital.

BreakingsDec 18, 2024 19:05

Express News | China Resources Boya Bio-pharmaceutical Group: The products of its wholly-owned subsidiary are expected to win bids in the tenth national centralized procurement.

BreakingsDec 16, 2024 18:35

Express News | China Resources Boya Bio-pharmaceutical Group: The wholly-owned subsidiary Xinbai Pharmaceutical's product Alprostadil Aminohexyl Injection is proposed to be selected for national centralized procurement of Pharmaceuticals.

BreakingsDec 16, 2024 18:32

china resources boya bio-pharmaceutical group (300294): Focus on core business to enhance profitability.

Investment highlights: The leading company in the blood product segment with improved profitability is the blood product platform of China Resources Health sector, which offers 9 varieties and 23 specifications of products, covering three major categories: human albumin, human immunoglobulin, and coagulation indicators, among which the core products are.

guolianDec 3, 2024 13:52